Local Anesthetics in Pain Management

Local Anesthetics in Pain Management: Pharmacology & Safety Protocols

1. Mechanism of Action & Nerve Blockade

Local anesthetics prevent conduction of nerve impulses by reversibly binding to the intracellular domain of voltage-gated sodium (Na+) channels. By stabilizing the inactivated state, local anesthetics inhibit rapid depolarization and action potential propagation in peripheral nerve fibers (C > A-delta > A-beta sensitivity).

2. Chemical Classification & Physicochemical Properties

Class

Linkage Type & Clearance

Drug Examples

Key Physicochemical Properties

Amino-Esters

Ester linkage; rapidly hydrolyzed by plasma pseudocholinesterases

Procaine, Tetracaine, Chloroprocaine, Cocaine

Metabolized to PABA (risk of allergic hypersensitivity reactions)

Amino-Amides

Amide linkage; metabolized by hepatic CYP450

Lidocaine, Bupivacaine, Ropivacaine,

Extremely low allergy risk; potential for liver toxicity

Mechanism of Action & State-Dependent Block:

Local anesthetics block voltage-gated Na channels by entering the cell membrane in an uncharged form, becoming protonated intracellularly, and binding to the inner pore vestibule.
They exhibit use-dependent (frequency-dependent) block, binding with higher affinity when channels are rapidly firing during active nociception.
Potency & Duration: Driven by lipid solubility and protein binding (e.g., Bupivacaine and Ropivacaine bind heavily to tissue/plasma proteins, giving long duration).
Onset of Action: Dictated by the drug’s pKa relative to physiological pH (7.4); agents with a pKa closer to 7.4 (e.g., Lidocaine, pKa 7.8) have a higher non-ionized fraction for faster onset.

Interventional Block Anatomy & Applications:

Neuraxial Blocks: Epidural and intrathecal injections for multi-segmental somatic/visceral analgesia.
Fascial Plane Blocks: Transversus Abdominis Plane (TAP), Erector Spinae Plane (ESP), and Serratus Anterior blocks targeting spinal rami for thoracic and abdominal analgesia.
Autonomic Plexus Blocks: Stellate ganglion, Celiac plexus, and Superior hypogastric blocks for sympathetically-maintained neuropathic and visceral cancer pain.

3. Local Anesthetic Systemic Toxicity (LAST) & Lipid Rescue Protocol

Accidental intravascular injection or rapid absorption leads to high systemic concentrations, manifesting as progressive CNS and cardiovascular toxicity:

CNS Manifestations: Initial excitation (perioral numbness, metallic taste, tinnitus, agitation, seizures) followed by CNS depression (coma, respiratory arrest).
Cardiovascular Manifestations: Conduction delay, severe bradycardia, ventricular arrhythmias, and refractory cardiovascular collapse (Bupivacaine exhibits high cardiac toxicity due to slow dissociation from cardiac Na+ channels).

CLINICAL GUIDELINE SUMMARY: ASRA Practice Advisory: Lipid Emulsion Resuscitation Protocol
Upon first signs of LAST, secure airway, administer 100% oxygen, and immediately bolus 20% Intralipid (Lipid Emulsion Therapy) at 1.5 mL/kg IV over 1 minute, followed by a continuous infusion of 0.25 mL/kg/min. Lipid emulsion acts as a ‘lipid sink’ to extract lipophilic local anesthetic from cardiac tissue.

References

ASRA Practice Advisory: Neal JM, et al. American Society of Regional Anesthesia and Pain Medicine Checklist for Managing Local Anesthetic Systemic Toxicity: 2017 Version. Reg Anesth Pain Med. 2018;43(2):150-153.
Anesthesia Reference: Hadzic A, ed. Hadzic’s Textbook of Regional Anesthesia and Acute Pain Management. 2nd ed. McGraw-Hill; 2017.

Related Posts